Disseminated varicella zoster virus infection following live attenuated herpes zoster vaccine: descriptive analysis of reports to Australia’s spontaneous vaccine pharmacovigilance system, 2016–2020
Objectives To examine the reported incidence and features of disseminated varicella zoster virus (VZV) infection following live attenuated herpes zoster vaccine live (ZVL: Zostavax, Merck) in immunocompromised people in Australia.Design and setting ZVL was funded in 2016 in Australia for people aged...
Main Authors: | Catherine Glover, Kristine Macartney, Anastasia Phillips, Jean Li-Kim-Moy, Adelaide Morgan, Sanjay Jayasinghe, Brynley P Hull, Aditi Dey, Frank H Beard, Megan Hickie |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-01-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/13/1/e067287.full |
Similar Items
-
Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study
by: Anita E Heywood, et al. -
Varicella and herpes zoster vaccine development: lessons learned
by: Charlotte Warren-Gash, et al.
Published: (2017-12-01) -
Routine varicella vaccination program and hospitalization for herpes zoster in Japan
by: Yasutaka Kuniyoshi, et al.
Published: (2021-11-01) -
Meningo-encephalitis and herpes zoster-varicella
by: Kerawala SDD
Published: (1965-01-01) -
Prevention of Herpes Zoster: A Focus on the Effectiveness and Safety of Herpes Zoster Vaccines
by: Yasmin Marra, et al.
Published: (2022-11-01)